228 related articles for article (PubMed ID: 20887114)
21. Papilledema in obstructive hydrocephalus caused by giant cell astrocytoma of tuberous sclerosis.
Chong DY; Hirunwiwatkul P; McKeever PE; Trobe JD
J Neuroophthalmol; 2007 Mar; 27(1):50-4. PubMed ID: 17414875
[TBL] [Abstract][Full Text] [Related]
22. Recurrent meningitis associated with frontal sinus tuber encephalocele in a patient with tuberous sclerosis.
Elbabaa SK; Riggs AD; Saad AG
J Neurosurg Pediatr; 2011 Jul; 8(1):103-6. PubMed ID: 21721896
[TBL] [Abstract][Full Text] [Related]
23. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Kotulska K; Chmielewski D; Borkowska J; Jurkiewicz E; Kuczyński D; Kmieć T; Łojszczyk B; Dunin-Wąsowicz D; Jóźwiak S
Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018
[TBL] [Abstract][Full Text] [Related]
24. Gradual formation of an operative corridor by balloon dilation for resection of subependymal giant cell astrocytomas in children with tuberous sclerosis: specialized minimal access technique of balloon dilation.
Levine NB; Collins J; Franz DN; Crone KR
Minim Invasive Neurosurg; 2006 Oct; 49(5):317-20. PubMed ID: 17163349
[TBL] [Abstract][Full Text] [Related]
25. mTOR inhibitors in the treatment of subependymal giant-cell astrocytomas associated with tuberous sclerosis.
Komotar RJ; Starke RM; Connolly ES; Sisti MB
Neurosurgery; 2011 Apr; 68(4):N24-5. PubMed ID: 21792104
[No Abstract] [Full Text] [Related]
26. [Subependymal giant cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; Carceller F; Hernández-Moneo JL; Gutiérrez-Molina M; Morales C
Neurologia; 2010 Jun; 25(5):314-21. PubMed ID: 20643042
[TBL] [Abstract][Full Text] [Related]
27. [Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex].
Mateos-González ME; López-Laso E; Vicente-Rueda J; Camino-León R; Fernández-Ramos JA; Baena-Gómez MA; Peña-Rosa MJ
Rev Neurol; 2014 Dec; 59(11):497-502. PubMed ID: 25418144
[TBL] [Abstract][Full Text] [Related]
28. Everolimus tablets for patients with subependymal giant cell astrocytoma.
Turner SG; Peters KB; Vredenburgh JJ; Desjardins A; Friedman HS; Reardon DA
Expert Opin Pharmacother; 2011 Oct; 12(14):2265-9. PubMed ID: 21806479
[TBL] [Abstract][Full Text] [Related]
29. Neonatal subependymal giant cell astrocytoma: new case and review of literature.
Raju GP; Urion DK; Sahin M
Pediatr Neurol; 2007 Feb; 36(2):128-31. PubMed ID: 17275668
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous sclerosis complex: should we always use contrast enhancement?
Gaillard AL; Crombé A; Jecko V; Bessou P; Havez M; Pédespan JM; Van Gils J; Chateil JF
Pediatr Radiol; 2020 Sep; 50(10):1397-1408. PubMed ID: 32671416
[TBL] [Abstract][Full Text] [Related]
31. [A case of tuberous sclerosis associated with a pineal region tumor].
Kurimoto M; Ohara S; Nakagaki S; Aoki S; Mori M
No Shinkei Geka; 1987 Feb; 15(2):167-71. PubMed ID: 3561682
[TBL] [Abstract][Full Text] [Related]
32. Subependymal giant cell tumors in tuberous sclerosis complex.
Goh S; Butler W; Thiele EA
Neurology; 2004 Oct; 63(8):1457-61. PubMed ID: 15505165
[TBL] [Abstract][Full Text] [Related]
33. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis.
Gyure KA; Prayson RA
Mod Pathol; 1997 Apr; 10(4):313-7. PubMed ID: 9110292
[TBL] [Abstract][Full Text] [Related]
34. Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex.
Yalon M; Ben-Sira L; Constantini S; Toren A
Childs Nerv Syst; 2011 Jan; 27(1):179-81. PubMed ID: 20703486
[TBL] [Abstract][Full Text] [Related]
35. Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex.
Major P
Aging (Albany NY); 2011 Mar; 3(3):189-91. PubMed ID: 21415462
[TBL] [Abstract][Full Text] [Related]
36. The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex.
Amin S; Carter M; Edwards RJ; Pople I; Aquilina K; Merrifield J; Osborne JP; O'Callaghan FJ
Eur J Paediatr Neurol; 2013 Jan; 17(1):36-44. PubMed ID: 23183057
[TBL] [Abstract][Full Text] [Related]
37. Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex.
Jiang T; Du J; Raynald ; Wang J; Li C
World Neurosurg; 2017 Nov; 107():1053.e1-1053.e6. PubMed ID: 28866062
[TBL] [Abstract][Full Text] [Related]
38. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
[TBL] [Abstract][Full Text] [Related]
40. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U
J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
